CUSHMAN & WAKEFIELD PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 10.55 USD | +1.05% |
|
+5.29% | -2.31% |
| Apr. 29 | Cushman & Wakefield Reports No Adjusted Profit or Loss in Q1, Revenue Declines | MT |
| Apr. 29 | Transcript : Cushman & Wakefield plc, Q1 2024 Earnings Call, Apr 29, 2024 |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- The stock, which is currently worth 2024 to 0.49 times its sales, is clearly overvalued in comparison with peers.
- Over the last 4 months, analysts have significantly revised upwards the company's estimated sales.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Real Estate Services
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -2.31% | 2.42B | C+ | ||
| -3.08% | 27.21B | B+ | ||
| +5.49% | 20.81B | C- | ||
| -26.30% | 9.97B | C- | ||
| -18.04% | 9.67B | B- | ||
| +3.70% | 9.31B | B+ | ||
| -4.03% | 6.78B | C- | ||
| -6.97% | 5.73B | B+ | ||
| +46.70% | 4.83B | - | - | |
| -10.07% | 2.21B | C |
Investor Rating
Trading Rating
ESG Refinitiv
Financials
Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Environment
Emissions
Innovation
Use of resources
Governance
CSR Strategy
Management
Shareholders
Controversy
Controversy
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- CWK Stock
- Ratings Cushman & Wakefield plc
